Browsed by
Tag: Strengthens

Arena Pharmaceuticals’ Presence at United European Gastroenterology Week Strengthens Ongoing Commitment to the Gastrointestinal Disease Community

Arena Pharmaceuticals’ Presence at United European Gastroenterology Week Strengthens Ongoing Commitment to the Gastrointestinal Disease Community

SAN DIEGO, Oct. 9, 2020 /PRNewswire/ — Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will present new data from the Phase 2 OASIS trial and its open-label extension for its investigative drug candidate etrasimod, a next-generation, once-daily, oral, highly selective sphingosine 1-phosphate (S1P) receptor modulator, in patients with moderately to severely active ulcerative colitis (UC) at the 26th Annual United European Gastroenterology (UEG) Week. Arena will also present preclinical data for olorinab, a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2 (CB2), in development for the treatment of visceral pain in gastrointestinal (GI) diseases. UEG Week is taking place virtually October 11-13, 2020.

Arena Sponsored Symposium Details: 
Title: Opening the Door to Emerging Investigational Treatments in Ulcerative Colitis: What Awaits Us?
Intended Audience: This symposium is designed for non-US healthcare professionals and is not affiliated with UEGW
Speakers: William Sandborn, MD (Chair), Professor Silvio Danese, Remo Panaccione, MD, FRCPC
Day/Time: Monday, October 12 at 17:30 CET

Presentation Details:
Title: Early and Durable Symptom Control in Patients with Moderately to Severely Active Ulcerative Colitis Treated with Etrasimod in the Randomised, Double Blind, Placebo Controlled, Phase 2 OASIS Trial and Open Label Extension
Day/Time: Tuesday, October 13, 2020, from 15:00-16:00 CET
ePoster: P0481

Title: Expression of Cannabinoid Receptors and the Effect of Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, on Visceral Hypersensitivity in Rodent Models of Irritable Bowel Syndrome and Inflammatory Bowel Disease 
Day/Time: Sunday, October 11, 2020, 18:00-19:00 CET    
Oral presentation: OP058    

Title: The Incremental Increasing Rate of Thromboembolic Events in Patients with Inflammatory Bowel Disease Compared to Patients Without Autoimmune Disorder   
Event: Virtual poster exhibition
ePoster: P0377                    

About Etrasimod
Etrasimod (APD334) is a once-daily, oral, highly selective sphingosine 1-phosphate (S1P) receptor modulator, discovered by Arena, designed

Read the rest
SolarWindow Expands U.S. Operations to Asia and Strengthens Management Team

SolarWindow Expands U.S. Operations to Asia and Strengthens Management Team

SolarWindow Technologies, Inc. (Symbol: WNDW), developer of transparent electricity-generating coatings for glass and plastics, today announced corporate expansion of its US operations through newly established commercial development offices in South Korea, repeatedly ranked number one in the worldwide Bloomberg Innovation Index and a leading country in advanced manufacturing of new technologies and products.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201005005517/en/

Alexandra Musk, Associate VP, Brand & Business Development,SolarWindow Technologies, Inc. (Photo: Business Wire)

“Only a few weeks ago, we demonstrated our largest and most transparent SolarWindow™ glass panes generating electricity from sunlight and artificial indoor light,” stated Mr. Jay S. Bhogal, CEO and President of SolarWindow. “This milestone achievement spurred today’s expansion of our operations and cross-functional business teams in the United States and Korea.”

The Company’s newly formed Asia business unit with its strategic hires and expanded operations places SolarWindow in a geography that is home to some of the world’s most advanced-technology manufacturers of next-generation building materials, electric vehicles and commercial transportation systems, and consumer electronics — a natural fit with the Company’s proprietary LiquidElectricity™ coatings for films, glass, and plastics.

“With this expansion, SolarWindow taps into high tech manufacturing in new markets while strengthening our position as a Made-in-America energy solution with global implications,” continued Mr. Bhogal. “With rising global demand for efficient, sustainable, and cost-competitive solutions, now is the time to apply our proprietary clean energy source — the application of our LiquidElectricity™ coatings — to flat window glass and to products far beyond.”

Bridging US & Asia Business Development: Ms. Alexandra Musk

Bridging U.S. and Asian SolarWindow offices is newly appointed Associate VP Brand & Business Development, Ms. Alexandra Musk, who brings a family legacy of innovative, sustainable ventures in renewable energy and electric vehicles.

Based in California, Ms.

Read the rest